Clinical Trials Browser

Tyrosine Kinase Inhibitors × Thoracic × 30 days × Clear all

NCT04318938 2026-03-02

Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping

Phase 2 Active not recruiting

NSCLC